Brian M. Silver - Net Worth and Insider Trading
Brian M. Silver Net Worth
The estimated net worth of Brian M. Silver is at least $240,718 dollars as of 2024-04-27. Brian M. Silver is the CFO of TScan Therapeutics Inc and owns about 32,885 shares of TScan Therapeutics Inc (TCRX) stock worth over $240,718. Details can be seen in Brian M. Silver's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian M. Silver has not made any transactions after 2022-12-28 and currently still holds the listed stock(s).
Transaction Summary of Brian M. Silver
Brian M. Silver Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian M. Silver owns 1 companies in total, including TScan Therapeutics Inc (TCRX) .
Click here to see the complete history of Brian M. Silver’s form 4 insider trades.
Insider Ownership Summary of Brian M. Silver
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRX | TScan Therapeutics Inc | 2022-12-28 | Chief Financial Officer |
Brian M. Silver Latest Holdings Summary
Brian M. Silver currently owns a total of 1 stock. Brian M. Silver owns 32,885 shares of TScan Therapeutics Inc (TCRX) as of December 28, 2022, with a value of $240,718.
Latest Holdings of Brian M. Silver
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRX | TScan Therapeutics Inc | 2022-12-28 | 32,885 | 7.32 | 240,718 |
Holding Weightings of Brian M. Silver
Brian M. Silver Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian M. Silver has made a total of 5 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in TScan Therapeutics Inc is the acquisition of 6,000 shares on December 28, 2022, which cost Brian M. Silver around $9,240.
Insider Trading History of Brian M. Silver
- 1
Brian M. Silver Trading Performance
GuruFocus tracks the stock performance after each of Brian M. Silver's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian M. Silver is -4.96%. GuruFocus also compares Brian M. Silver's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian M. Silver within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brian M. Silver's insider trading performs compared to the benchmark.
Performance of Brian M. Silver
Average Return
14.18%
Outperforming Transactions
20%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.15 | -4.96 | -21.53 | 14.18 | -19.45 | |
| Relative Return to S&P 500(%) | 0.73 | -6.38 | -21.28 | 17.49 | -21.79 |
Brian M. Silver Ownership Network
Ownership Network List of Brian M. Silver
Ownership Network Relation of Brian M. Silver
Brian M. Silver Owned Company Details
What does TScan Therapeutics Inc do?
Who are the key executives at TScan Therapeutics Inc?
Brian M. Silver is the Chief Financial Officer of TScan Therapeutics Inc. Other key executives at TScan Therapeutics Inc include Chief Accounting Officer Leiden Dworak , 10 percent owner Weston Nichols , and 10 percent owner Lynx1 Capital Management Lp .
TScan Therapeutics Inc (TCRX) Insider Trades Summary
Over the past 18 months, Brian M. Silver made 1 insider transaction in TScan Therapeutics Inc (TCRX) with a net purchase of 6,000. Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 67,027 shares made by Timothy J Barberich , a net sale of 25,400 shares made by Lynx1 Capital Management Lp , and a net purchase of 5,000 shares made by Barbara Klencke .
In summary, during the past 3 months, insiders sold 0 shares of TScan Therapeutics Inc (TCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,400 shares of TScan Therapeutics Inc (TCRX) were sold and 78,027 shares were bought by its insiders, resulting in a net purchase of 52,627 shares.
TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
TScan Therapeutics Inc Insider Transactions
Brian M. Silver Mailing Address
Above is the net worth, insider trading, and ownership report for Brian M. Silver. You might contact Brian M. Silver via mailing address: C/o Tscan Therapeutics, Inc., 830 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
